Credit Suisse’s Zomedica Corp. ZOM Stock Holding History

Credit Suisse’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,151	Closed	–	–	4555
2022 Q2	$0	Sell	2,151 -535,818	-100%	-$136K	﹤0.01%	4615
2022 Q1	$182K	Buy	537,969 +39,290	+8%	+$12.9K	﹤0.01%	3396
2021 Q4	$153K	Sell	498,679 -75,231	-13%	-$33.9K	﹤0.01%	4332
2021 Q3	$301K	Sell	573,910 -959	-0.2%	-$566	﹤0.01%	4087
2021 Q2	$479K	Buy	574,869 +561,709	+4,268%	+$523K	﹤0.01%	3871
2021 Q1	$20K	Buy	+13,160	New	+$21.5K	﹤0.01%	4256
2019 Q2	–	Sell	-10,990	Closed	-$4K	–	4299
2019 Q1	$4K	Buy	+10,990	New	+$9.7K	﹤0.01%	3959
2018 Q3	–	Sell	-10,157	Closed	-$23K	–	4098
2018 Q2	$23K	Buy	+10,157	New	+$20.4K	﹤0.01%	3932

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse's ZOM Position: Q3 2022 in Review

Credit Suisse sold out of Zomedica Corp. (ZOM) in Q3 2022, closing a stake of 2,151 shares.

Credit Suisse first reported a position in ZOM in Q2 2018 and held it in 8 quarters. The position peaked at $479K in Q2 2021. 87 funds tracked by Wall St. Rank hold ZOM as of Q3 2022.

Credit Suisse reported no remaining Zomedica Corp. position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 2,151 Zomedica Corp. shares in Q3 2022.
Credit Suisse first reported a position in Zomedica Corp. in Q2 2018 and held it in 8 quarters.
Credit Suisse's Zomedica Corp. position peaked at $479K in Q2 2021.
87 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.